Literature DB >> 15953551

Ral GTPases: corrupting the exocyst in cancer cells.

Jacques H Camonis1, Michael A White.   

Abstract

The Ras-like small G-proteins RalA and RalB have achieved some notoriety as components of one of a growing variety of candidate Ras effector pathways. Recent work has demonstrated that Ral GTPase activation is required to support both the initiation and maintenance of tumorigenic transformation of human cells. The mechanistic basis for this support remains to be defined. However, the discovery that the exocyst is a direct effector complex for activated Ral proteins suggests that mobilization of polarized exocytosis might be a basic component of the biological framework supporting tumorigenic progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953551     DOI: 10.1016/j.tcb.2005.04.002

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  49 in total

1.  c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.

Authors:  Rafael B Blasco; Sarah Francoz; David Santamaría; Marta Cañamero; Pierre Dubus; Jean Charron; Manuela Baccarini; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-04-21       Impact factor: 31.743

2.  RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.

Authors:  Vincent Neyraud; Vasily N Aushev; Anastassia Hatzoglou; Brigitte Meunier; Ilaria Cascone; Jacques Camonis
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

3.  A big new job for small GTPases.

Authors:  Ana Carmena
Journal:  Small GTPases       Date:  2012-05-31

Review 4.  The Exocyst at a Glance.

Authors:  Bin Wu; Wei Guo
Journal:  J Cell Sci       Date:  2015-08-03       Impact factor: 5.285

5.  Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion.

Authors:  Hezhe Lu; Jianglan Liu; Shujing Liu; Jingwen Zeng; Deqiang Ding; Russ P Carstens; Yusheng Cong; Xiaowei Xu; Wei Guo
Journal:  Dev Cell       Date:  2013-12-09       Impact factor: 12.270

6.  A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles.

Authors:  Sang-Hyuk Chung; Kristopher K Frese; Robert S Weiss; B V Venkataram Prasad; Ronald T Javier
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

7.  RalA promotes a direct exocyst-Par6 interaction to regulate polarity in neuronal development.

Authors:  Amlan Das; Sangeetha Gajendra; Katarzyna Falenta; Madeleine J Oudin; Pascal Peschard; Shanshan Feng; Bin Wu; Christopher J Marshall; Patrick Doherty; Wei Guo; Giovanna Lalli
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

Review 8.  Emerging roles for the non-canonical IKKs in cancer.

Authors:  R R Shen; W C Hahn
Journal:  Oncogene       Date:  2010-11-01       Impact factor: 9.867

9.  RalA-exocyst complex regulates integrin-dependent membrane raft exocytosis and growth signaling.

Authors:  Nagaraj Balasubramanian; Jeremy A Meier; David W Scott; Andrés Norambuena; Michael A White; Martin Alexander Schwartz
Journal:  Curr Biol       Date:  2009-12-10       Impact factor: 10.834

10.  Akt-PDK1 complex mediates epidermal growth factor-induced membrane protrusion through Ral activation.

Authors:  Hisayoshi Yoshizaki; Naoki Mochizuki; Yukiko Gotoh; Michiyuki Matsuda
Journal:  Mol Biol Cell       Date:  2006-11-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.